Immune anemia is medically known as autoimmune hemolytic anemia, and medication should be chosen according to different types, such as warm antibody type can be treated with prednisone and cold antibody type can be treated with rituximab. Immune hemolytic anemia is an acquired hemolytic disease, divided into warm antibody type autoimmune hemolytic anemia and cold antibody type autoimmune hemolytic anemia. 1. Warm antibody type: manifested by progressive anemia, jaundice, hepatosplenomegaly, often with hemoglobinuria. A few may have skin and mucous membrane bleeding. Glucocorticoid is the drug of choice for the treatment of autoimmune hemolytic anemia of the warm antibody type, and the common drugs are prednisone, dexamethasone, methylprednisolone and so on. If glucocorticoid and splenectomy treatment can not achieve remission, can be used for acute treatment of immunosuppressive drugs, commonly used drugs are cyclophosphamide, azathioprine, cyclosporine, etc.. 2. Cold antibody type: this type is relatively rare, mainly for the cause of the treatment. Keeping warm is the most important therapeutic measure. When glucocorticoid treatment alone is not good, rituximab can be added, and other treatments are the same as warm antibody type. All of the above medications should be used under the guidance of a doctor, avoid self-medication.